Short Summary
ClearCorrect seeks to invalidate Align Technology's 2023 patent on multilayer dental aligners, arguing that all claims are obvious over prior‑art references such as Kalili, Porter, Texin 990R, Wen, and Tadros. The petition requests the PTAB to institute review and cancel the challenged claims.
Detailed Summary
In Petition IPR2025-00821, ClearCorrect Operating, LLC challenges U.S. Patent No. 11,648,091, which claims multilayer polymer sheets and dental aligners with specific mechanical properties. The petitioner contends that the claims are unpatentable under 35 U.S.C. §103 because a person of ordinary skill in the art would have been motivated to combine the teachings of Kalili (a two‑layer aligner), Porter (Tritan copolyester properties), Texin 990R (TPU properties), Wen (advantages of thinner sub‑layers), and Tadros (soft‑hard‑soft configurations) to arrive at the claimed inventions. The petition also notes a lack of written description and enablement under §112, though this does not affect the obviousness analysis. ClearCorrect requests that the Board institute inter‑ partes review and cancel claims 1‑23 and 25‑26.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in ClearCorrect Operating, LLC et al. vs Align Technology, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Taiwan Semiconductor Manufacturing Company LimitedvsMarlin Semiconductor Ltd. et al.
The PTAB granted institution for IPR2025-01265, allowing the trial to proceed after determining the petitioner had a reasonable likelihood of prevailing. This notice also details multiple other institutional decisions across various proceedings.
Apple Inc.vsHBCU Messaging US LP
Apple has filed a Request for Director Review seeking to overturn a PTAB decision that denied institution of its IPR against HBCU Messaging’s MMS patent. The petitioner argues that its claim‑construction positions are consistent with district‑court rulings and that the Board improperly applied the Revvo discretionary denial. Apple asks that the decision be vacated and the case be instituted on the merits.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck has filed a Post‑Grant Review petition challenging Halozyme’s U.S. Patent No. 12,054,758 covering engineered PH20 hyaluronidase proteins, arguing lack of written description, enablement, and obviousness.
MWE Investments, LLC et al.vsChampion Power Equipment, Inc.
The PTAB granted settlement motions filed by Harbor Freight Tools USA Inc. and MWE Investments, LLC, terminating the IPRs against them while the case continues for Generac Power Systems, Inc.
Samsung Electronics Co., Ltd. et al.vsRadian Memory Systems LLC
Samsung Electronics and Radian Memory Systems settled their IPR disputes before trial, resulting in the termination of seven pending IPRs, including IPR2025-01350 covering patent 11,740,801.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.